Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

68.01
Delayed Data
As of Sep 23
 -1.87 / -2.68%
Today’s Change
58.21
Today|||52-Week Range
133.74
-32.52%
Year-to-Date

Today’s Trading

Previous close69.88
Today’s open69.12
Day’s range67.83 - 70.73
Volume373,011
Average volume (3 months)571,073
Market cap$2.3B
Data as of 4:00pm ET, 09/23/2019

Growth & Valuation

Earnings growth (last year)+24.45%
Earnings growth (this year)+4.50%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+37.30%
P/E ratioNM
Price/Sales15.96
Price/Book108.31

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-0.79-2.60%
PTCTPTC Therapeutics Inc+0.11+0.28%
FOLDAmicus Therapeutics ...-0.33-3.49%
AGIOAgios Pharmaceutical...+0.30+0.83%
Data as of 4:00pm ET, 09/23/2019

Financials

Next reporting dateOctober 28, 2019
EPS forecast (this quarter)-$2.46
Annual revenue (last year)$179.8M
Annual profit (last year)-$309.2M
Net profit margin-171.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Operating Officer
Jerome B. Durso
Corporate headquarters
New York, New York

Forecasts